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Context: Kidney is one of the vital organs maintaining homeostasis of body and thus 
dysfunction of kidney affects quality of life and health severely. Anticancer drugs, 
particularly chemotherapeutic agents, cause high toxicity leading kidney dysfunction 
and irreparable kidney injury. Therefore, attention has recently been paid to seeking out 
alternatives such as nature-based drugs that are effective but less toxic. In this regard, this 
systematic review article is to report and introduce the most important medicinal plants 
and their derivatives that are used to reduce anticancer drug-induced nephrotoxicity. 
Evidence Acquisitions: The word nephrotoxicity alongside the words cancer or chemotherapy 
in combination with some herbal terms such as medicinal plant, plants, herbs, and extracts 
were administered to search for relevant publications indexed in PubMed. 
Results: According to this study, 16 medicinal plants, 12 plant-based derivatives, and three 
traditional plant-based formulations were found to help control and modulate anticancer 
drug-induced nephrotoxicity indices. 
Conclusions: Anticancer drugs cause nephrotoxicity through activating pathways of oxidative 
stress, damage-associated molecular patterns (DAMPs) production, inflammatory 
processes, and cell apoptosis, while medicinal plants and their derivatives can cause 
reduction in nephrotoxicity and anticancer drugs side effects via their antioxidant and 
anti-inflammatory properties. 
ABSTRACT
Implication for health policy/practice/research/medical education:
Nephrotoxicity is one of  the most common side effects induced by anticancer drugs and severely affects the patients’ lives. 
It plays a significant role in the process of  cancer treatment. The findings of  this review article will provide researchers and 
pharmacists with keys to identification of  new medicinal plants to modulate and reduce nephrotoxicity and therefore explain 
routes to accelerate use of  natural product drugs in healthcare system.
Please cite this paper as: Heidari-Soreshjani S, Asadi-Samani M, Yang Q, Saeedi-Boroujeni A. Phytotherapy of  nephrotoxicity-
induced by cancer drugs: an updated review. J Nephropathol. 2017;6(3):254-263. DOI: 10.15171/jnp.2017.41.
1. Context
Cancer is one of  the most important causes of  death 
worldwide such that around 14 million new cases of 
cancer and 8.2 million deaths due to cancer were reported 
in 2012. Therefore, early diagnosis and appropriate 
treatment are considered to be among the most 
important measures to reduce mortality among cancer 
patients (1). Although many chemotherapeutic agents 
are currently available to treat a variety of  cancers, side 
effects due to these drugs have brought about certain 
limitations facing use of  them and eradication of  cancer. 
For example, anticancer drugs are associated with 
nephrotoxicity, i.e. one of  the most common anticancer 
drug-induced side effects, which can cause temporary or 
permanent kidney injury and even endanger the lives of 
cancer patients and therefore intensify their conditions 
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(2-4). Studies have shown that nephrotoxicity is the 
cause of  acute renal injuries in 60% of  all clinical 
cases, and is induced mainly by anticancer drugs and 
associated with several side effects and mortality (2,5). 
Nephrotoxicity can be diagnosed through simple blood 
tests. Assessment of  nephrotoxicity through blood 
tests includes the measurements of  blood urea nitrogen 
(BUN), concentration of  serum creatinine, glomerular 
filtration rate and creatinine clearance.
Anticancer drugs, including cisplatin, oxaliplatin, 
bleomycin, ifosfamide, carboplatin,  mitomycin 
C, bendamustine,  melphalan, vinca, nitrosoureas, 
methotrexate, capecitabine, irinotecan, gemcitabine 
and pemetrexed (6-10), play roles in induction of 
nephrotoxicity. Administration of  natural products 
such as medicinal plants is one of  the effective 
approaches to reduce the complications of  various 
diseases with fewer side effects (11-17). They can be 
used to reduce anticancer drug-induced side effects 
because of  the good safety and tolerability profile of 
natural compounds in human (18-21). In this review we 
report the progress made in utilizing medicinal plants in 
protecting anticancer drug-induced nephrotoxicity and 
discuss their mechanisms of  action.
2. Evidence Acquisition
To retrieve relevant articles to this systematic review, 
EndNote software was used. Moreover, the word 
nephrotoxicity alongside the words cancer or chemotherapy in 
combination with some herbal terms such as medicinal 
plant, plant, herb and extracts were administered to 
search for relevant publications indexed in PubMed as 
the most important medical database.
By means of  different combinations of  the above 
search terms, 162 articles on nephrotoxicity, cancer, and 
chemotherapy that were related to medicinal plants were 
retrieved while 81 of  which were duplicate publications. 
After excluding duplicate publications, 81 articles were 
identified by a fully specialized search and their abstracts 
analyzed. Among these articles, only those that mainly 
investigated the effects of  the medicinal plants and 
their derivatives in reducing anticancer drug-induced 
nephrotoxicity were selected and the data needed for 
this systematic review article were drawn. 
3. Results 
3.1. Phytotherapy for anticancer drug-induced nephrotoxicity 
3.1.1 Herbal extracts
Pomegranate: Pomegranate has antioxidant, anti-
inflammatory and antimicrobial effects. It is reported 
that different parts of  pomegranate can prevent 
cisplatin-induced nephrotoxic side effects. Pomegranate 
seed extract causes decrease in lipid peroxidation and 
increase in glutathione S-transferase level and activities 
of  superoxide dismutase, glutathione peroxidase, and 
glutathione S-transferase. Pomegranate seed extract 
could prevent nephrotoxicity side effects in laboratory 
rats due to antioxidant and antiapoptotic properties 
(22). A study demonstrated that pomegranate seed 
essential oil reduced glucose, protein, serum urate, 
renal malondialdehyde (MDA), and serum creatinine 
and increased thiol levels (23). Karwasra et al studied 
the effects of  pomegranate rind extract in induction of 
nephrotoxicity and renal injuries. The administration 
of  pomegranate rind extract significantly ameliorated 
increased serum creatinine and BUN, which were 
induced by cisplatin. In addition, pomegranate exhibited 
antiapoptotic activity due to the decreased activity of 
caspase-3 expression (24). 
Administration with pomegranate flower extract 
accompanied by cisplatin has been reported to reduce 
cisplatin renal toxicity. Moreover, if  administered with 
cisplatin alone, this extract can decrease blood nitrite 
and tissue damage to renal glomeruli in rats (25). 
However, Jilanchi et al reported that pomegranate 
flower extract aggravated renal injuries induced by 
cisplatin in rats (26). Also, Nasri and Rafieian-Kopaei 
(27) and El-Arabey (28) have argued that pomegranate 
flower extract does not seem to be effective as an 
antioxidant agent in reducing cisplatin nephrotoxicity 
in female rats, which may be due to the pro-oxidant 
activity or use of  low doses of  this extract in the 
studies. Besides, due to containing phytoestrogens 
and having estrogenic property, pomegranate flower 
causes increase in cisplatin nephrotoxicity. Therefore, 
the effects of  pomegranate seeds have been considered 
mainly in reducing cisplatin-induced nephrotoxic side 
effects as these seeds are frequently used in traditional 
medicine and no side effects induced by pomegranate 
seeds have yet been reported. 
Garlic: A study to investigate the protective effect 
of  garlic (Allium sativum) on methotrexate-induced 
nephrotoxicity in rats demonstrated that aqueous A. 
sativum extract caused increase in filtration, improved 
renal function and activities of  antioxidant enzymes. 
Moreover, garlic extract decreases oxidative stress 
and prevents morphological changes in the kidney 
(5). Because of  exerting antioxidant, antiapoptotic, 
and anti-inflammatory effects, garlic decreases MDA 
level and improves kidney action. In addition, garlic 
extract protects cisplatin-induced side effects including 
histomorphological, ultrastructural, and biochemical 
changes (29).
Green tea: Green tea (Camellia sinensis) is a frequently used 
plant in traditional medicine. Studies on the protective 
effects of  green tea against cisplatin nephrotoxicity in 
male rat showed  that green tea can not only reduce 
cisplatin destructive changes, but also is effective on 
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increased Pi transport activity (30). Compared with 
administration of  chemotherapy, administration of 
green tea and royal jelly demonstrated decreased BUN 
and serum creatinine accompanied with increased 
glutathione level and MDA production in mice (31).
Grape: Grape contains large amounts of  antioxidant 
phytochemicals such polyphenols, reseveratrol and 
proanthocyanidins. A study on renal protective effects 
of  grape juice (with skin and seed) showed that no 
significant change was observed in oxidative stress and 
antioxidant status in the kidneys of  cisplatin-treated 
mice. However, tubular cell vacuolization, tubular 
dilatation, and cast formation in kidney tubules were 
slightly improved after pretreatment with whole grape 
juice (32). Therefore, given the inconsistent findings of 
the studies and exerting certain beneficial effects, grape 
should be further studied for its effects on the protection 
against anticancer drug-induced renal toxicity. 
Curcuma caesia Roxb.: C. caesia Roxb. is traditionally 
used in treating various ailments and metabolic 
disorders in Indian system of  medicine. The protective 
effects of  C. caesia Roxb. against chemotherapeutic 
drug cyclophosphamide was evaluated. The study 
showed that cyclophosphamide exerted toxicity on 
the kidney and liver in mice, and use of  methanolic C. 
caesia Roxb extract reduced serum levels of  aspartate 
aminotransferase (AST) and alanine transaminase 
(ALT) and kidney peroxidation in the treatment group 
(33).
Rubia cordifolia: R. cordifolia, which is commonly used in 
Indian traditional medicine, is from family Rubiaceae 
and has antioxidant properties. A study on R. cordifolia 
extract effects in cisplatin-treated mice demonstrated 
that this plant reduced serum creatinine and urea levels 
as well as lipids peroxidation, and therefore could 
modulate nephrotoxicity side effects (34). 
Phyllanthus fraternus: P. fraternus is a tropical plant from 
family Euphorbiaceae whose pharmaceutical uses have 
recently attracted pharmacologists’ attention. Aqueous 
P. fraternus extract can reduce renal disorders induced by 
anticancer drugs such as cisplatin and cyclophosphamide. 
This plant can modulate mitochondrial respiratory 
disorders and lipids peroxidation (35). 
Peach: In Asia, different parts of  peach (Prunus 
persica)  are used as herbs. Lee et al studied the effect 
of  peach pericarp extract (PPE) on cisplatin-induced 
nephrotoxicity demonstrated that PPE controlled 
cisplatin-induced increase in urea and creatinine in mice 
and modulated nitric oxide, glutathione content, and 
lipids peroxidation (36). A similar study reported that 
peach flesh extract had similar effects to peach seeds 
and also reduced kidney weight loss in animal models 
(37). 
Sphaeranthus indicus: S. indicus, which is also referred to 
as east Indian globe thistle, is used for treating several 
diseases, but few studies have conducted on this plant. 
Use of  ethanolic extract of S. indicus 10 days after 
administration with cisplatin was effective in reducing 
the nephrotoxicity indices such as BUN level and 
serum creatinine level. It also increased antioxidant 
indices (superoxide dismutase, catalase, and glutathione 
peroxidase) in mice kidney and regulated glutathione 
level (38). 
Urtica dioica L.: U. dioica, commonly referred to as common 
nettle, has long been used in traditional medicine. Ozkol 
et al have studied the antitoxic effects of  common 
nettle in mice kidney and liver after administration with 
cisplatin. It showed that methanolic common nettle 
extract exerted preventive effect through decreasing 
BUN level, lipids peroxidation, myeloperoxidase, and 
proteins oxidation due to its antioxidant properties. 
Moreover, it could decrease the activities of  certain 
enzymes such as superoxide dismutase, glutathione 
S-transferase, catalase, and glutathione peroxidase as 
well as glutathione content (39).
Soybean: The effect of  the extract of  soybean (Glycine 
max) on cisplatin-toxified human proximal tubular HK-2 
cells was investigated and demonstrated antioxidant 
effects on H2O2 (40).
Chrysanthemum indicum: C. indicum is an Indian flowering 
plant. Pongjit et al investigated anti-nephrotoxic effects 
of  this plant and found it can prevent of  apoptosis in 
of  human proximal tubular cells and display antioxidant 
activity against H2O2 and OH
- (40).
Origanum majorana: O. majorana, commonly called 
marjoram, is an aromatic plant that can control cisplatin-
induced nephrotoxic side effects such as increased 
renal functional markers including BUN, urea, uric acid, 
and serum creatinine, and modulate cisplatin-induced 
oxidative markers (41). 
Ribes diacanthum Pall: In Mongolia, R. diacanthum is used 
as a remedy for urinary tract complications. Aqueous 
R. diacanthum extract in cisplatin-treated mice caused 
decrease in some toxicity biomarkers such as BUN and 
serum creatinine, increase in the activities of  certain 
enzymes including heme oxygenase 1, reduction in 
superoxide dismutase, increase in catalase, and inhibition 
of  lipids peroxidation and other reactive oxygen species 
(ROS) (42). 
Pueraria tuberosa DC.: P. tuberosa is used in Ayurvedic 
medicine, India’s primary healthcare system. P. tuberosa 
powder prevented cisplatin-induced nephrotoxicity 
in mice due to antioxidant property. Therefore, this 
plant can be administered as a supplement to prevent 
nephrotoxicity (43). 
Glycyrrhizia glabra: As a crude extract, licorice extract 
obtained from the dried root of  G. glabra is widely 
administered in Chinese traditional medicine. Its 
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nephrotoxic effects are due to antioxidant properties. 
Administration with licorice extract inhibited all 
side effects due to cisplatin-induced nephrotoxicity 
including increased serum creatinine and BUN as well 
as intensified oxidative stress in mice. However, since 
the therapeutic efficacy (destruction of  tumor cells) 
of  licorice extract was reduced in combination with 
cisplatin, it is recommended to use this extract alone 
rather than in combination with cisplatin for exerting 
anticancer effect (44). 
3.1.2. Compounds
Catechin, epigallocatechin-gallate, and epigallocatechin: The 
compounds found in green tea such as catechin, 
epigallocatechin gallate (EGCG), and epigallocatechin 
have been reported to be effective in protection against 
nephrotoxicity (45). A study on cisplatin-treated 
mice demonstrated that pretreatment with green tea 
polyohenols (EGCG, and epigallocatechin) decreased 
toxic changes and cisplatin-induced side effects and 
improved renal function in the mice under treatment (46). 
In addition, El-Mowafy et al found that administration 
of  20-40 mg/kg of  green tea catechin and EGCG led 
to decrease in tumor necrosis factor alpha (TNF-α) 
and MDA and increased glutathione level. In addition, 
EGCG can suppress systemic inflammation and 
prevent oxidative stress and leukocytosis. Therefore, 
this polyohenol has been reported to prevent incidence 
of  side effects and mortality due to cisplatin-induced 
nephrotoxicity in rats (47).
Proanthocyanidins: Grape can inhibit apoptotic and 
necrotic cell processes and prevent anticancer drug-
induced tissue toxicity in all cells of  the body, due 
to proanthocyanidins found in grape seed (48).  A 
study indicated that grape seed proanthocyanidins 
led to decrease in nephrotoxicity induced by drugs, 
especially anticancer ones. That study showed that 
grape seed proanthocyanidins could prevent oxidative 
stress, genomic integrity, and cell death (49). The 
proanthocyanidins found in grape seed can prevent 
cisplatin-induced cytotoxic side effects in the kidney 
through modifying expression of  the proteins 
associated with apoptosis and antioxidant property 
(50). Gao et al investigated the protective effects of 
grape seed proanthocyanidin extract on nephrotoxicity 
in male laboratory mice, and found that cotreatment 
with proanthocyanidins and cisplatin could result 
in decreased BUN level, renal index, and serum 
creatinine. Therefore, proanthocyanidins protects 
nephrotoxicity through weakening endoplasmic 
reticulum stress-induced apoptosis via regulating 
caspase-12 (51). Proanthocyanidins are phenolic 
compounds whose properties are dose-dependent and 
that cause improvement of  renal function mainly due to 
antioxidant property (52). 
PTY: PTY is an isoflavonoid compound derived from 
tubers of  Pueraria tuberosa. Use of  PTY increases 
the activities of  catalase and superoxide dismutase, 
decreases glutathione content and index biomarkers in 
nephrotoxicity (BUN and serum creatinine). Besides, 
PTY causes decline in tubular inflammation, damage 
to DNA, protein cast deposition, and tissue damage. 
Therefore, the antioxidant properties of  PTY can 
regulate renal function in mice (53). 
Resveratrol: Resveratrol is a polyphenol found in white 
hellebore (Veratrum grandiflorum O Loes) root, apple, and 
grape as well as in other medicinal plants. Resveratrol is 
a protective agent against chemotherapy drug-induced 
nephrotoxicity. This compound has antioxidant, 
anti-inflammatory, and antiapoptotic activities and 
can suppress cisplatin-induced cytotoxic effects (54-
56). Indications of  renal injury and toxicity such as 
increased serum creatinine level and urine proteins in 
resveratrol-treated mice were reported to be lower than 
those in controls. Furthermore, administration with 
resveratrol caused decrease in glutathione depletion and 
lipids peroxidation (57,58). This compound has anti-
inflammatory properties and suppresses oxygen species 
activity. Resveratrol antioxidant property is associated 
with decreased 4-HNE and carbonyl adduction (57). A 
study demonstrated that in cisplatin-treated rats, serum 
creatinine, urine protein and volume, lipids peroxidation, 
and glutathione depletion increased. Such changes and 
nephritis were mitigated in resveratrol-treated rats (59). 
Cardamonin: Cardamonin is a flavonoidic compound 
that is found in various plants including alpinia plant. 
Study of  the nephroprotective properties of  alpinia 
demonstrated that cardamonin led to decrease in 
caspase-3 expression and Bax/Bcl-2 ratio, and could 
decrease NOX-1 expression in mice, therefore reduce 
nephrotoxicity (60). 
Ginsenosides: Ginseng contains an active and antioxidant 
compound named ginsenoside 20(S)-Rg3 that is used as 
a medicine to treat renal disorders in some regions of 
the world. Use of  this plant-based compound prevents 
cisplatin-induced apoptosis in porcine LLC-PK1 
cells through inhibiting JNK-p53-caspase-3 signaling 
cascade (61). Furthermore, damage to the LLC-PK1 
cells is reduced due to treatment with ginsenosides 
Rg3, Rg5, and Rk1 and processed ginseng. Moreover, 
expressions of  p53 and c-Jun N-terminal kinase (JNK) 
proteins that are reduced by cisplatin are restored. This 
antitoxic activity of  ginseng active compounds is due 
to their anti-inflammatory and antiapoptotic properties 
(62). Moreover, other compounds of  ginseng (Rh4 and 
Rk3) can decrease the induced nephrotoxicity in the 
LLC-PK1 cells (63). 
Luteolin: Luteolin is a flavonoidic and plant-based 
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compound with anticancer, anti-inflammatory, and 
antioxidant properties. A study investigated the effect 
of  luteolin demonstrated that cisplatin led to increased 
levels of  bax, caspase-3, and PUMA-α as well as p53 
and its phosphorylation activity. Treating mice with 
luteolin can significantly eliminate side effects and 
therefore modulate p53-dependent renal tubular 
apoptosis and consequently nephrotoxicity (64). 
Moreover, luteolin was reported to inhibit apoptosis of 
renal cells, and leads to improved renal function and 
nephrotoxicity indices (histological and biochemical) 
and prevents accumulation of  platinum in mice 
kidneys through inactivating nuclear factor-kappaB 
(NF-κB) and decreasing the expression of  TNF-α 
and cyclooxygenase-2 (COX-2)  through  suppressing 
oxidative/nitrosative stress  by increasing glutathione 
levels and decreasing 3-nitrotyrosine (3-NT) and 
4-hydroxynonenal (4-HNE) formation as well as 
cytochrome P450 2E1 (CYP2E1) expression (65). 
Silymarin: Silymarin is a plant-based flavonoid compound 
of  Silybum marianum. Silymarin exerts anti-inflammatory 
effect through decreasing TNF-α and reduces acute 
nephrotoxicity through protecting erythrocytes 
lysis. This plant reduces BUN and serum creatinine 
and therefore cisplatin-induced nephrotoxicity in 
patients, which is attributed to its immunomodulatory, 
antioxidant, and anti-inflammatory properties (66). 
Tetrahydrocurcumin: Tetrahydrocurcumin is a 
compound from curcuminoids of  tumeric root that 
displays anti-inflammatory properties in preventing 
cisplatin-induced nephrotoxicity through preventing 
the activities of  certain enzymes such as caspase-3 and 
cyclooxygenase-2 (67). 
Lycopene: Carotenoids including lycopene are among 
the most potent antioxidants and prevent other oxidants 
from inducing toxic effects in the body. Hassan et 
al (50) reported that lycopene prevented cisplatin 
nephrotoxicity in mice through a complex process. 
Indeed, lycopene exerts its effects through reducing 
serum creatinine and BUN, preventing increase in MDA 
and isoprostane, decreasing renal bax protein as well as 
renal HSP60 and HSP70, increasing Bcl-2 expression, 
and decreasing lipids peroxidation (68). A study 
indicated that use of  lycopene before or after cisplatin 
administration could significantly protect the kidney 
against cisplatin-induced nephrotoxicity and improved 
blood markers in rats through increasing glomerular 
filtration and decreasing serum creatinine, urea, and 
concentration of  MDA (69). Erman et al demonstrated 
that use of  lycopene after cisplatin administration 
caused decrease in BUN and serum creatinine levels 
and efflux transport proteins MRP2 and MRP4 in the 
studied animals. Moreover, in the lycopene -treated 
group, organic cation transporter 1 and 2 proteins and 
organic anion transport 1 and 3 proteins were regulated. 
These changes caused reduction in nephrotoxicity (70). 
3.1.3. Traditional herbal prescriptions and pharmaceutical 
formulations
HemoHim: HemoHim is a medicinal plant that is 
produced by adding the ethanol-insoluble fraction to 
the total water extract of  a mixture of  three edible 
herbs, Angelica radix, Cnidium rhizoma, and Paeonia 
radix. This drug causes reduction in cisplatin-induced 
nephrotoxicity through exerting antioxidant properties. 
A study on mice with cancer under treatment with 
cisplatin demonstrated that HemoHim could increase 
the activity of  natural killer cells and Tc cells as well as 
the IL-2 and IFN-gamma secretion from splenocytes. 
Moreover, in addition to enhancing anticancer effects of 
cisplatin, HemoHim causes reduction in nephrotoxicity 
through prevention of  tubular cell destruction in the 
kidneys (71). 
Cystone: Cystone is a combination of  some plants that 
is used to treat renal complications in Himalaya and 
some other regions. Rao et al found that cystone could 
decrease BUN and serum creatinine of  laboratory 
mice after five days of  treatment with cisplatin without 
disturbing cisplatin function at a specific dose (72). 
Moreover, in a randomized clinical trial on 49 patients 
with cancer, treatment with cystone and cisplatin caused 
significant decrease in levels of  BUN, serum creatinine, 
and serum cystatin C compared to treatment with 
cisplatin alone. Therefore, cystone can help decrease 
nephrotoxic side effects of  cisplatin without interfering 
with the treatment process (59). 
Wuzhi tablet: Wuzhi tablet is a pharmaceutical 
formulation derived from ethanolic Schisandra 
sphenanthera extract. The most important chemical 
compound of  this formulation is Schisantherin. 
Nuclear accumulation of  Nrf2 and Nrf2-dependent 
genes increased in the mice treated with Wuzhi tablet. 
Actually Wuzhi tablet decreases nephrotoxicity through 
the activation of  Nrf2/ARE pathway in HK-2 cells and 
the kidney of  mice. Therefore Wuzhi tablet can balance 
defense responses for decreasing nephrotoxicity in 
mice (73). 
3.2. Implications and mechanisms 
Renal tubular cells are particularly susceptible to 
toxins. Renal injuries are mainly due to inappropriate 
exposure of  these cells to circulation of  chemical 
compounds and transfer of  substances that cause 
escalation of  intracellular toxin concentrations. Overall, 
chemical compounds or their metabolites exert toxicity 
through developing covalence or non-covalence 
bonds in macromolecules or via ability to produce 
ROS (74). Several mechanisms are likely to induce 
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nephrotoxicity including direct damage to DNA and 
induction of  oxidative stress due to accumulation of 
drugs in renal cells that can directly or indirectly cause 
increase in ROS, mitochondrial dysfunction, increase in 
inflammation factors, renal cell death due to necrosis 
and apoptosis as well as inflammation (Figure 1). In 
most cited studies, cisplatin, serving as one of  the most 
important anticancer drugs, was reported to induce 
nephrotoxicity. This drug enters renal epithelial cells 
and causes damage to DNA and induction of  stress in 
the endothelial network. Then, the arrangements for 
apoptosis and necrosis are made through production 
of  ROS and activation of  mitochondrial and non-
mitochondrial apoptosis-dependent pathways. Besides 
that, extensive apoptosis and cell death initiate an 
extensive inflammatory response that may lead to 
nephrotoxicity and renal damage (2,6).
Moreover, during toxin-induced changes in the renal 
cells, the proteins and lipids in the membrane, nucleus, 
lysosome, mitochondria, and cytosol are collectively 
targeted. In case of  oxidative stress, lipids peroxidation 
and proteins oxidation occur, which exacerbates cell 
damage. In many cases, mitochondrion is an important 
target, and adenosine triphosphate (ATP) deficiency 
leads to cell damage due to aerobic metabolism-
dependent renal function. In addition, ATP deficiency 
causes certain disorders in the process of  distributing the 
genes, which leads ultimately to escalation of  calcium ion 
and cell death. In addition, oxidative stress contributes 
to cell death through production of  cysteine protease 
(73). Moreover, expansion of  renal injuries, particularly 
acute renal injury, which is due to certain chemical 
compounds could cause an increase in serum urea and 
creatinine and decrease in the kidney cleaning capacity. 
Besides that, decrease in renal perfusion, hematuria, 
proteinuria, cylinduria, and oliguria are some other side 
effects of  this condition that occur due to inflammation 
and lysis of  the renal cells (75-77). These changes 
decrease the rate of  renal filtration (78). Accordingly, 
administration with antioxidants could be a novel and 
proper approach to treat anticancer drug-induced 
nephrotoxicity (79). Indeed, anticancer drugs exert their 
destructive effects, and pathways of  oxidative stress, 
inflammatory processes, and cell apoptosis contribute 
significantly to these changes. The role of  antioxidant 
and anti-inflammatory compounds found in plants 
and plant-based compounds in removing side effects 
has been highlighted in most studies (80-84). However, 
antioxidant compounds and even certain plant-based 
extracts used to prevent and reduce nephrotoxicity 
should be administered under supervision a physician 
and cautiously (85-87). Taken together, given many side 
effects of  anticancer drugs such as nephrotoxicity, bone 
marrow suppression, and hepatotoxicity, it is necessary 
to seek out an alternative approach, namely use of 
medicinal plants or herbal medicines or chemical drugs 
(88,89). However, there are still some controversies 
over use of  antioxidants alongside anticancer drugs, 
because it has been demonstrated that excessive 
use of  antioxidants interferes with the process of 
chemotherapy and cancer treatment (90). Therefore, it 
seems still essential to determine the active dose and 
cutoff  point of  the antioxidant compounds (91-93). 
Nephrotoxicity may be affected by certain factors such 
Figure 1.  Role of  medicinal plants in ameliorating nephrotoxicity-induced by anticancer drugs.
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as drug dosage, use frequency, cumulative dose, aging, 
gender, smoking, hypoalbuminemia, and history of 
chronic renal failure that are considered risk factors for 
cisplatin-induced nephrotoxicity as well. These factors 
too can be considered confounders and therefore 
influence the findings (6). Duration of  administration 
with herbal drugs is another issue that may challenge the 
reliability of  the findings. According to this review article 
and several studies, herbal drugs and their compounds 
could be used alongside chemical drugs as pretreatment, 
co-treatment, or post-treatment. Therefore, it can 
be assumed that increased serum concentrations of 
active plant-based compounds, chemical drugs, drug 
interactions, and production of  toxic metabolites have 
been investigated less frequently and most studies 
have been conducted with animal models.  Moreover, 
given that using serum creatinine and BUN can delay 
diagnosis of  nephrotoxicity, it is necessary to use 
other biomarkers to diagnose nephrotoxicity and start 
its treatment earlier. In addition, it is recommended 
to investigate renal biochemical markers thoroughly 
as well as to take into account necessary standards 
to achieve high sensitivity and accelerate study of 
nephrotoxicity. Determining active dose of  the plants 
and their derivatives to reduce nephrotoxicity should be 
taken into consideration more seriously. 
4. Conclusions 
According to the current review article, anticancer 
drugs induce nephrotoxicity especially through 
activating pathways of  oxidative stress, inflammatory 
processes, and cell apoptosis. The medicinal plants and 
their derivatives can reduce nephrotoxicity and other 
side effects induced by these drugs through exerting 
antioxidant and anti-inflammatory properties (Figure 1). 
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